Objectives: Graves' hyperthyroidism (GH) interferes with iron metabolism and elevates ferritin. The precise mechanisms remain unclear. The influence of thyroid hormones on the synthesis/regulation of hepcidin, an important regulator of iron metabolism, remains uncharacterized.
In severe hyperthyroidism normochromic, normocytic anaemia may be associated with impaired iron use. 1, 2 These anaemias are unresponsive to haematinic therapy 2 (ie substitution with iron, vitamin B12 or folate) and vanish once normal thyroid function is restored.
On the other hand, there are manifold effects of thyroid hormones on iron metabolism.
Iron acts as an important cofactor in fundamental biochemical processes, for example oxygen transport. High iron concentrations are toxic, and therefore, iron metabolism in the body is highly regulated. Several proteins play a critical role in iron metabolism. Iron, bound to transferrin, is transported within the plasma and internalized by receptor-mediated endocytosis. Intracellular ferritin is principally responsible for storage and buffering of excess iron. 3 Hepcidin, a liver-derived peptide hormone, is one of the most important regulators of iron homeostasis. It lowers plasma iron by downregulating ferroportin 1 (FPN-1), which promotes iron efflux out of cells (enterocytes, hepatocytes or macrophages). 4, 5 The bioactive form of hepcidin (hepcidin-25) contains 25 amino acids.
Smaller isoforms (hepcidin-24, hepcidin-23, hepcidin-22) are usually present in conditions characterized by elevated hepcidin-25 levels; however, the biological significance of these isoforms remains unclear.
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Acute-phase reactions lead to substantial changes in iron metabolism and are characterized by high levels of ferritin and hepcidin and low levels of iron and transferrin. 3 Animal models of hyperthyroidism demonstrate decreased circulating plasma iron and increased hepatic iron and ferritin. In addition, hepatic ferritin synthesis is increased, although hepatic albumin synthesis remains unchanged. 9 In hyperthyroid states, plasma erythropoietin (EPO) levels are high, erythropoiesis is increased, and bone marrow is hypercellular. 2, 10, 11 Hence, iron turnover due to augmented iron utilization is increased, but iron overload is absent, 2, 10, 12 and the concomitant expansion of plasma volume masks the increase in red blood cell mass. 12 The observed decline in plasma iron levels can be explained by faster incorporation of iron into haeme;
however, any impact of hepcidin remains speculative because there are no data regarding the influence of thyroid hormones on hepcidin synthesis and regulation. Case reports and case series have described transiently elevated ferritin levels in hyperthyroid patients that decreased after achieving a euthyroid state. [13] [14] [15] [16] Whereas some studies found a positive correlation between levels of thyroid hormones and ferritin, 15 others did not. 14 Furthermore, the mechanisms of hyperthyroidismassociated hyperferritinaemia remain poorly understood.
Here, we hypothesize that thyroid hormones directly influence iron metabolism by affecting ferritin and/or hepcidin levels. Therefore, the aims of this study were as follows:
• To quantify the levels of ferritin, hepcidin and other parameters related to iron metabolism (eg transferrin) in patients with Graves' hyperthyroidism (GH) and in the same patients after they had achieved euthyroidism.
• To investigate potential mechanisms by measuring inflammatory parameters and cytokines and to set these measurements in relation to gender and smoking status.
• To study the impact of thyroid hormones on hepatic hepcidin expression using a cell culture model.
| SUBJECTS AND METHODS
This was a prospective observational study. The subjects consisted of patients who attended our outpatient clinic with newly diagnosed and untreated Graves' hyperthyroidism (GH Measurement of cytokines was performed using a flowcytometric method. quantitative real-time PCR was performed as described. 18 Hepcidin primers (Hs00221783_m1) were purchased from Applied Biosystems (ThermoFisher Scientific, Waltham, MA, USA).
| Laboratory assessment

| Cell culture
| Statistical analysis
The values for each parameter were compared at baseline (T0) and follow-up (T1), as defined above. Initially, data were analysed descriptively by calculating medians and interquartile ranges (IQRs). The statistical significance of any differences was established using the including also patients with partially missing data (hepcidin could not be measured in six patients at T0, one patient had no measurements of cytokines at T0), with no alteration of the results or conclusions.
The main exposure of interest in our multivariable analysis was the time point (baseline T0 or follow-up T1). The following variables were considered for model adjustment: age, gender, smoking status and time between baseline and follow-up (in days). We also tested for interactions with gender and smoking status. These interaction tests were specified a priori and were based on existing evidence in the literature. The variables were manually added to the model in an incremental fashion, and the results were inspected visually. The final models only included those adjustments that exerted a substantial impact on the point estimate for the time point (>20%) and interaction terms with P < .1. All data analyses were performed using Stata SE version 13.1 (StataCorp LLC, College Station, TX, USA). Statistical significance was defined as P < .05. All tests were two-sided. No adjustments for multiple testing were performed.
| RESULTS
Thirty-one patients (22 females, nine males; mean age 48 years [range 26-82]) were included in the study. Twelve of thirty-one (38%) patients were smokers. The median (IQR) thyroid volume was 13.9 (10.6-23.1) mL, and thyroid parameters are displayed in Table 1 Figure 2 ). Changes between T0 and T1 did not reach statistical significance when hepcidin was measured by ELISA (hepcidin EL , Table 1 ). There was no correlation detected between anti-TSH receptor antibody (TRAb) titres and ferritin/hepcidin levels (data not shown).
| Multivariable regression analyses
The following four parameters were also subjected to multivariable regression analyses: ferritin, hepcidin MS , fT3 and fT4 ( 
| Cell culture model
To investigate whether elevated hepcidin levels in hyperthyroid subjects might be directly driven by high fT3 levels, experiments were performed in a human liver cell line. As shown in Figure 4 , T3 treatment significantly induced hepcidin mRNA expression in HepG2 cells, consistent with the findings in patients.
| DISCUSSION
The results of our study are threefold: (i) GH leads to changes in iron metabolism that resemble a classical "acute-phase reaction," that is, elevation of ferritin and hepcidin and a decline of transferrin and iron levels. These changes seem to be (in part) independent from inflammatory parameters and normalize after achieving euthyroid function. ; however, the effect of the high EPO levels in hyperthyroid patients 10 on hepcidin synthesis may be overridden by other factors (eg thyroid hormones).
New-onset GH can be interpreted as a form of acute-phase or inflammatory reaction, but markers of inflammation and inflammatory cytokines in our patients were not affected neither by thyroid function nor by smoking status. These findings are in concordance with other studies where circulating serum cytokines are unchanged in GH patients 25 or only partially elevated.
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Therefore, a direct hormonal influence on the physiology of ferritin and hepcidin must be assumed. Cell culture models indeed demonstrated that ferritin gene transcription was induced by insulin/IGF-1,
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TSH 28 and T3 29 and that the latter modulates post-transcriptional mechanisms via iron regulatory proteins (IRPs). 29 This is the first study to show a direct effect of T3 on hepcidin mRNA expression in a human liver cell line, which is consistent with the clinical finding of elevated hepcidin levels in our hyperthyroid subjects. Of note, the impact of T3 stimulation on hepcidin production in HepG2 cells was assessed on mRNA but not on protein levels, as hepcidin production may mainly be regulated at transcriptional level. 30 In our study population, ferritin and hepcidin levels showed wide variability and were higher in men than in women. The influence of gender on ferritin 31 and hepcidin 32 is well known. Oestrogen inhibits hepcidin synthesis 33 and hepcidin levels are lower in premenopausal subjects 32 and in women with high endogenous oestrogen levels resulting from in vitro fertilization procedures. 34 In our study, the majority (16/22) of the female patients were premenopausal and thus had lower hepcidin levels, which may have contributed to the difficulty in detecting differences in hepcidin levels between T0 and T1 in female subjects.
Compared to smokers, nonsmokers had significantly higher fT3
and fT4 values at T0. Smoking has an impact on various aspects of thyroid function and the development of thyroid disease. 35 Smokers are exposed to higher thiocyanate levels, 36 which can affect T3 and T4 concentrations, 37 mainly through its inhibitory effect on iodine trapping. 38 In addition, lower T3 and T4 levels have been described in smokers with normal thyroid function. 39, 40 However, to the best of our knowledge, the impact of smoking on T3 and T4 levels in patients with hyperthyroidism and GH has not been described until now.
In comparison with other studies, [13] [14] [15] [16] this study had the advantages of including only patients with GH, using longitudinal assessments of laboratory values and measuring a novel variable related to iron metabolism (hepcidin). Our study design allowed us to compare and demonstrate the dynamic changes in ferritin and hepcidin that occur in the same individuals during thyroid hyperfunction and after the achievement of normal thyroid function. This approach allowed the elimination of high interindividual variability in ferritin and hepcidin levels.
Another strength of our study was the use of mass spectrometry, the most accurate method for the quantification of bioactive hepcidin.
A recently published study 34 found no differences in circulating hepcidin levels in 20 patients with hyperthyroidism (17 with GH, two with subacute thyroiditis and one with toxic nodular goitre). However, hepcidin levels in that study were measured by ELISA only, which has the drawback of low specificity and accuracy. This is in line with our findings showing no statistically significant differences in hepcidin levels between time points when hepcidin levels were measured using ELISA.
The study has two principal limitations: the sample size was small and only fraction of the factors (eg cytokines) that are known to influence the levels of proteins involved in iron metabolism were measured. Thus, we were unable to elucidate fully the complex regulation of iron metabolism in hyperthyroid patients.
From a clinical point of view, knowledge of these dynamic changes and the underlying mechanisms is critical, allowing the clinician to estimate the impact of thyroid function abnormalities on these parameters, to consider other differential diagnoses and to prevent unnecessary investigations (eg for clarification of hyperferritinaemia).
The role of these acute-phase mechanisms in GH in the clinical context should be further elucidated. As with cytokines 41 or TRAb titres, 42 hepcidin and ferritin levels could have a potential role as parameters for predicting relapse of GH after thyrostatic treatment. However, this topic has to be clarified in future studies.
In conclusion, our study results indicate that iron metabolism in patients with GH undergoes dynamic changes that are comparable to an acute-phase reaction. Gender and smoking status had an impact on parameters of iron metabolism and thyroid hormones, in contrast to inflammatory parameters and cytokines, which were unaffected by thyroid status. For the first time, we were able to demonstrate that hepcidin, a key regulator of human iron metabolism, is affected in Graves' hyperthyroidism and that thyroid hormones had a direct effect on expression of this protein in hepatocytes.
